FIBROGEN INC — Director's Dealing 2016

Jan 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-01-28

Reporting Person: Neff Thomas B (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-28	Common Stock	S	12600	$19.17	Disposed	3650807	Direct
2016-01-28	Common Stock	S	900	$19.70	Disposed	3649907	Direct
2016-01-29	Common Stock	S	12800	$19.58	Disposed	3637107	Direct
2016-01-29	Common Stock	S	700	$20.17	Disposed	3636407	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	145070	Indirect
Common Stock	20000	Indirect
Common Stock	60946	Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: The shares were sold at prices ranging from $18.65 to $19.64. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: The shares were sold at prices ranging from $19.65 to $19.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: The shares were sold at prices ranging from $19.08 to $20.03. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: The shares were sold at prices ranging from $20.09 to $20.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6: The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.